🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the firms concealed safety concerns that the medication posed to children's brain development.

The lawsuit comes four weeks after Former President Trump advocated an unproven link between taking acetaminophen - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the only pain reliever recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "betrayed America by making money from suffering and marketing drugs ignoring the risks."

Kenvue states there is insufficient reliable data linking Tylenol to autism.

"These corporations misled for generations, intentionally threatening numerous people to increase profits," Paxton, a Republican, stated.

Kenvue stated officially that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the likely effects that could have on the health of women and children in America."

On its website, the company also stated it had "regularly reviewed the relevant science and there is no credible data that indicates a proven link between using acetaminophen and autism spectrum disorder."

Associations acting on behalf of medical professionals and health professionals share this view.

ACOG has said paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to address discomfort and fever, which can create significant medical dangers if not addressed.

"In multiple decades of investigation on the use of paracetamol in gestation, no reliable research has conclusively proven that the consumption of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in offspring," the organization said.

This legal action references recent announcements from the former administration in asserting the medication is potentially dangerous.

Recently, the former president caused concern from public health officials when he instructed pregnant women to "struggle intensely" not to consume acetaminophen when ill.

The FDA then released a statement that medical professionals should consider limiting the usage of acetaminophen, while also mentioning that "a direct connection" between the medication and autism in young ones has not been proven.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in April to conduct "extensive scientific investigation" that would establish the cause of autism in a matter of months.

But experts cautioned that discovering a single cause of autism - thought by researchers to be the outcome of a complex mix of inherited and surrounding conditions - would not be simple.

Autism is a type of lifelong neurodivergence and condition that impacts how people experience and relate to the environment, and is identified using doctors' observations.

In his legal document, Paxton - aligned with the former president who is seeking federal office - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism.

The case seeks to make the corporations "remove any commercial messaging" that claims Tylenol is secure for pregnant women.

The court case mirrors the concerns of a group of parents of minors with autism and ADHD who sued the manufacturers of Tylenol in recently.

Judicial authorities threw out the case, declaring studies from the family's specialists was lacking definitive proof.